DASSAULT SYSTÈMES ACQUIRES DRUG TRIAL SOFTWARE FIRM
■ AI-SUMMARIZED FROM 2 SOURCES ▸ TIMELINE
Dassault Systèmes SE is acquiring ArisGlobal, a drug trial software maker, for up to $2 billion. The deal marks the French company's continued expansion into life sciences software.
■ MORE FROM THE BIG TECH DESK
Google is rolling out a Live Game Feed feature for NFL games, offering real-time updates, play-by-play commentary, and AI-powered insights directly in search results on mobile.
Florida's attorney general filed a lawsuit Wednesday against Netflix, claiming the streaming platform misleads parents about data collection practices on minors and uses design features that encourage excessive viewing.
The American Federation of Teachers and Microsoft have agreed on privacy and safety standards for AI in educational settings, including legal liability provisions for data breaches.
A New Yorker investigation reveals how Flock Safety's camera network and data practices create a surveillance infrastructure with limited oversight and few mechanisms for individuals to opt out.